Navigation Links
Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial
Date:4/20/2009

- Updated Data from Initial Cohort Shows 11 of 17 Evaluable Patients Receiving Bavituximab in Combination with Carboplatin + Paclitaxel Achieved an Objective Tumor Response -

- Patient Dosing Initiated in Expansion Stage of Trial with Target of Enrolling 49 Patients Overall -

TUSTIN, Calif., April 20 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), today announced that updated preliminary data from the initial cohort of 21 patients in its Phase II trial evaluating bavituximab in combination with carboplatin and paclitaxel showed that 11 of 17 evaluable patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) achieved an objective tumor response according to RECIST criteria, after completing the maximum six treatment cycles. The company also reported that patient dosing is underway in the expansion stage of the trial, which will enroll an additional 28 patients for a total of 49 patients overall.

"We are very pleased to see these additional objective tumor responses in this difficult-to-treat cancer following the full regimen of six treatment cycles of bavituximab and chemotherapy," said Steven W. King, president and CEO of Peregrine. "These updated results build on the impressive data we reported after only four treatment cycles, which had already exceeded the pre-defined number of objective tumor responses needed to expand the trial to the larger cohort."

Mr. King added, "The tumor response data to date from this trial compares favorably to published studies with current standard-of-care lung cancer treatments, and we are looking forward to seeing results from the entire study. With dosing now underway in the expanded patient cohort, we expect to resume the brisk pace of enrollment achieved in the first cohort, with the goal of completing patient
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
2. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
3. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
4. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
5. Peregrine Pharmaceuticals Doses First Patient in Clinical Trial of Bavituximab in HCV Patients Co-Infected With HIV
6. Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
7. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
8. Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co-Infected With HIV
9. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
10. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
11. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... -- Salix Pharmaceuticals, Ltd. (the " Company " or " ... International, Inc. (NYSE: VRX ) (TSX:VRX), today announced ... Make-Whole Fundamental Changes and Merger Event, Fundamental Change Company ... to Purchase (the " Notice ") to holders of ... Notes "), pursuant to the Indenture, dated as of ...
(Date:4/1/2015)... Trinity Biotech plc (Nasdaq: TRIB ... products for the point-of-care and clinical laboratory markets, ... wholly-owned subsidiary (the "Issuer"), intends to offer, subject ... principal amount of Exchangeable Senior Notes due 2045 ... pursuant to Rule 144A under the Securities Act ...
(Date:4/1/2015)... , April 1, 2015  Pittman Motors ... introduction of PLG24, PLG42K, PLG42S, PLG52, and PLG63 ... Pittman brush and brushless DC motors and complement ... new products add 35 standard motor-gearbox family combinations ... planetary gearboxes deliver high torque loads with excellent ...
Breaking Medicine Technology:Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015 2Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015 3Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015 4Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015 5Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015 6Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015 7Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 2Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 3Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 4Pittman Motors Expands PLG Planetary Gearbox Offering 2
... Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that ... Health Care Conference on Wednesday, March 9, 2011 at 11:00 ... Interested parties may access a live webcast of the presentation ... It is recommended that listeners log on 15 ...
... A new ad campaign warns Mississippi legislators that ... prescription drug benefits and undermine the ability of pharmacy ... Mississippi families and businesses, said the Pharmaceutical Care Management ... put the State Board of Pharmacy (instead of the ...
Cached Medicine Technology:Onyx Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference 2New Ad Campaign: Secret Provision Raises Taxes on Prescription Drug Benefits, Creates 'Conflict of Interest' 2
(Date:4/1/2015)... New Jersey Governor First Spouse ... Spouses from across the country in sponsoring the ... World Down Syndrome Day(WDSD), to increase awareness of, ... of Down syndrome cognition research. , In addition ... American Samoa, Arizona, California, Colorado, Delaware, Florida, Guam, ...
(Date:4/1/2015)... It all began at home in the ... was on a mission to create a line of skincare ... parents could trust. Now, Shoosha Truly Organic is the only ... meaning all products contain a minimum 95% certified organic ingredients, ... is considered to be 40% thinner than adults and of ...
(Date:4/1/2015)... SCI Solutions , the health ... announced that CEO Joel French will be a featured ... Exhibition in Chicago, April 12-16, 2015. French will ... Care Coordination Strategies ” with Northeast Georgia Health System ... More than 38,000 healthcare industry professionals are expected at ...
(Date:4/1/2015)... San Diego, CA (PRWEB) April 01, 2015 ... promotion organization, is announcing two continuing medical education ... goal is to help practitioners become more confident ... to prevent disease. After completion of these CME ... , The CME courses available are ...
(Date:4/1/2015)... April 01, 2015 Like a mosaic ... the scientific understanding of the potential causes of rosacea. ... the National Rosacea Society (NRS) to educate the public ... facial disorder now estimated to affect more than 16 ... medical research on rosacea through its patient-funded research grants ...
Breaking Medicine News(10 mins):Health News:Governor First Spouses Join with New Jersey First Lady Mary Pat Christie to Support Advances in Biomedical Research to Treat Down Syndrome Cognitive Impairment 2Health News:Just in Time for Earth Day This April, Shoosha Truly Organic’s Skincare Line Soothes and Protects Mom and Baby’s Sensitive Skin with Pure, Simple and Organic Ingredients 2Health News:Just in Time for Earth Day This April, Shoosha Truly Organic’s Skincare Line Soothes and Protects Mom and Baby’s Sensitive Skin with Pure, Simple and Organic Ingredients 3Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 2Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 3Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 4Health News:GrassrootsHealth Launches CME Courses about Vitamin D 2Health News:GrassrootsHealth Launches CME Courses about Vitamin D 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 2Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 4Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 5
... detecting and analyzing tumor cells in the bloodstream are ... and long-term response to treatment. A report from ... Medicine in the March 31 Science Translational Medicine ... levels of circulating tumor cells (CTCs) in the blood ...
... UC Irvine Healthcare,s heart failure program and ... Gold Seal of Approval from The Joint Commission, ... Commission certification recognizes an organization,s diligence in meeting ... superior patient care. "This comprehensive, independent evaluation ...
... ... thrivers: Rochelle Togo-Figa is leading a movement to tackle the post-medical world of breast cancer, ... ... together women who have had breast cancer to inspire them to transform their experience into ...
... , ... and Functionality to Walk with Style , ... Portland, OR (PRWEB) March 31, 2010 -- Pat Heyward Canes, a new provider ... 36 exclusive designer patterns for men and women ranging from classic to whimsical. Made ...
... to each type of shot , WEDNESDAY, March 31 ... molecular and cellular reasons why some flu vaccines work ... better protection with fewer side effects. , "By understanding ... findings, not only the rationale for current live-attenuated influenza ...
... blueprint for humans , WEDNESDAY, March 31 (HealthDay News) -- ... muse on how far they,ve come and how far there ... the genome draft in 2001 permanently altered the scientific and ... come, according to scientists writing in the April 1 issue ...
Cached Medicine News:Health News:Improved device provides more rapid, comprehensive analysis of circulating tumor cells 2Health News:Medical center's heart failure, stroke programs recertified by Joint Commission 2Health News:Breast Cancer Survivor Tackles the Missing Link: Inspiring Event Offers Women Real Life Advice to Thrive After Medical Treatment Ends 2Health News:Breast Cancer Survivor Tackles the Missing Link: Inspiring Event Offers Women Real Life Advice to Thrive After Medical Treatment Ends 3Health News:Breast Cancer Survivor Tackles the Missing Link: Inspiring Event Offers Women Real Life Advice to Thrive After Medical Treatment Ends 4Health News:Pat Heyward Canes Unveils New Stylish Walking Cane Collection Just in Time for Mother's Day 2Health News:Clues Found to How Different Flu Vaccines Work 2Health News:Human Genome Turns 10 2Health News:Human Genome Turns 10 3
... Preformed into convenient shapes and sizes. Long-term ... smooth or textured surfaces. Each preformed block ... meet the exact specifications for a given ... specially pre-formed to provide a greater number ...
24-hour full disclosure , Input range: 5mV , Analog bandwidth: 0.05 to 100Hz (3dB) , Common mode rejection ratio: 60dB , Dimensions: 4.46in. x 2.75in. x 1.02in. (113mm x 70mm x 26mm) , We...
... the IQmark Digital Spirometer is a great addition ... Spirometer meets or exceeds the strict requirements of ... use. It supplies you with all the measurements ... FEV6 that is recommended by the NLHEP. , ...
... ingredients and Alpha-Beta and TCA to deliver ... been used for many years to treat ... of pregnancy and other superficial skin problems. ... removal of the upper layers of skin. ...
Medicine Products: